Your search matched 3 results
RARE RECRUITMENT | In The Media
Efforts to bring treatments to market for the approximately 7,000 rare diseases affecting more than 350 million people globally have been stepped up in recent years.
Health insurers have raised challenging questions about how drugs for rare diseases are defined, regulated, and priced in the U.S. market.
SHARING THE MISSION TO CONQUER RARE DISEASES | Perspectives
At an ever-quickening pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases.